Cargando…
Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685970/ https://www.ncbi.nlm.nih.gov/pubmed/32269318 http://dx.doi.org/10.1038/s41375-020-0814-0 |
| _version_ | 1783613271219109888 |
|---|---|
| author | Dun, Matthew D. Mannan, Abdul Rigby, Callum J. Butler, Stephen Toop, Hamish D. Beck, Dominik Connerty, Patrick Sillar, Jonathan Kahl, Richard G. S. Duchatel, Ryan J. Germon, Zacary Faulkner, Sam Chi, Mengna Skerrett-Byrne, David Murray, Heather C. Flanagan, Hayley Almazi, Juhura G. Hondermarck, Hubert Nixon, Brett De Iuliis, Geoff Chamberlain, Janis Alvaro, Frank de Bock, Charles E. Morris, Jonathan C. Enjeti, Anoop K. Verrills, Nicole M. |
| author_facet | Dun, Matthew D. Mannan, Abdul Rigby, Callum J. Butler, Stephen Toop, Hamish D. Beck, Dominik Connerty, Patrick Sillar, Jonathan Kahl, Richard G. S. Duchatel, Ryan J. Germon, Zacary Faulkner, Sam Chi, Mengna Skerrett-Byrne, David Murray, Heather C. Flanagan, Hayley Almazi, Juhura G. Hondermarck, Hubert Nixon, Brett De Iuliis, Geoff Chamberlain, Janis Alvaro, Frank de Bock, Charles E. Morris, Jonathan C. Enjeti, Anoop K. Verrills, Nicole M. |
| author_sort | Dun, Matthew D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7685970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76859702020-12-03 Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia Dun, Matthew D. Mannan, Abdul Rigby, Callum J. Butler, Stephen Toop, Hamish D. Beck, Dominik Connerty, Patrick Sillar, Jonathan Kahl, Richard G. S. Duchatel, Ryan J. Germon, Zacary Faulkner, Sam Chi, Mengna Skerrett-Byrne, David Murray, Heather C. Flanagan, Hayley Almazi, Juhura G. Hondermarck, Hubert Nixon, Brett De Iuliis, Geoff Chamberlain, Janis Alvaro, Frank de Bock, Charles E. Morris, Jonathan C. Enjeti, Anoop K. Verrills, Nicole M. Leukemia Letter Nature Publishing Group UK 2020-04-08 2020 /pmc/articles/PMC7685970/ /pubmed/32269318 http://dx.doi.org/10.1038/s41375-020-0814-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Dun, Matthew D. Mannan, Abdul Rigby, Callum J. Butler, Stephen Toop, Hamish D. Beck, Dominik Connerty, Patrick Sillar, Jonathan Kahl, Richard G. S. Duchatel, Ryan J. Germon, Zacary Faulkner, Sam Chi, Mengna Skerrett-Byrne, David Murray, Heather C. Flanagan, Hayley Almazi, Juhura G. Hondermarck, Hubert Nixon, Brett De Iuliis, Geoff Chamberlain, Janis Alvaro, Frank de Bock, Charles E. Morris, Jonathan C. Enjeti, Anoop K. Verrills, Nicole M. Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia |
| title | Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia |
| title_full | Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia |
| title_fullStr | Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia |
| title_full_unstemmed | Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia |
| title_short | Shwachman–Bodian–Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia |
| title_sort | shwachman–bodian–diamond syndrome (sbds) protein is a direct inhibitor of protein phosphatase 2a (pp2a) activity and overexpressed in acute myeloid leukaemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685970/ https://www.ncbi.nlm.nih.gov/pubmed/32269318 http://dx.doi.org/10.1038/s41375-020-0814-0 |
| work_keys_str_mv | AT dunmatthewd shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT mannanabdul shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT rigbycallumj shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT butlerstephen shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT toophamishd shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT beckdominik shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT connertypatrick shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT sillarjonathan shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT kahlrichardgs shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT duchatelryanj shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT germonzacary shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT faulknersam shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT chimengna shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT skerrettbyrnedavid shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT murrayheatherc shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT flanaganhayley shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT almazijuhurag shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT hondermarckhubert shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT nixonbrett shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT deiuliisgeoff shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT chamberlainjanis shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT alvarofrank shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT debockcharlese shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT morrisjonathanc shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT enjetianoopk shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia AT verrillsnicolem shwachmanbodiandiamondsyndromesbdsproteinisadirectinhibitorofproteinphosphatase2app2aactivityandoverexpressedinacutemyeloidleukaemia |